CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morley-Forster, P.
Right arrow Articles by Cook, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morley-Forster, P.
Right arrow Articles by Cook, M. J.

Canadian Journal of Anesthesia, Vol 40, 1126-1130, Copyright © 1993 by Canadian Anesthesiologists' Society

ARTICLES

Ketorolac and indomethacin are equally efficacious for the relief of minor postoperative pain

P Morley-Forster, PT Newton and MJ Cook
Department of Anaesthesia, St. Joseph's Health Centre, University of Western Ontario, London, Canada.

Injectable ketorolac is an effective analgesic in ambulatory surgery patients. However, no studies have compared ketorolac with other NSAIDs in this setting. The analgesic efficacy of intramuscular ketorolac, rectal indomethacin and placebo was compared in healthy women undergoing gynaecological or breast surgery as outpatients. Ninety patients received 30 mg im ketorolac, 100 mg pr indomethacin or placebo in a prospective, randomized, double-blind manner. A standardized anaesthetic protocol was followed. Patients graded their pain on a 10 cm visual analogue scale in the recovery room, twice in the surgical day care unit and during the car ride home. The patients' postoperative fentanyl requirements, time to recovery milestones, and side effects were recorded. The placebo group received more fentanyl in the PACU but did not achieve the same pain relief as either of the NSAID-treated group (ketorolac 44 +/- 53 micrograms, indomethacin 39 +/- 55 micrograms, placebo 87 +/- 100 micrograms, P < 0.05). Patients who received an NSAID had less pain at 15 and 90 min (P < 0.05). The PACU stay was longer for the placebo group (ketorolac 50 +/- 13 min, indomethacin 49 +/- 12 min, placebo 62 +/- 35 min, P < 0.05). Time to ambulation was also longer in the placebo group (ketorolac 117 +/- 25 min, indomethacin 121 +/- 49 min, placebo 140 +/- 51 min, P < 0.05). However, no differences were observed between the two NSAIDS. Side effects were similar in all groups. We conclude that im ketorolac and pr indomethacin are equally effective analgesics in this group of patients.


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
W.-w. Pang, M. S. Mok, M.-C. Ku, and M.-H. Huang
Patient-Controlled Analgesia with Morphine Plus Lysine Acetyl Salicylate
Anesth. Analg., October 1, 1999; 89(4): 995 - 995.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
S A Sadiq, L Stevenson, C Gorman, and G M Orr
Use of indomethacin for pain relief following scleral buckling surgery
Br. J. Ophthalmol., April 1, 1998; 82(4): 429 - 431.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Canadian Anesthesiologists' Society.